logo-loader

Viewing results 51-75 of 82

Health

Veritas kicks off coverage of Canada's cannabis industry with Sell ratings Canopy Growth, Aphria, Aurora Cannabis and Cronos

'Our analysis suggests that the market still lacks perspective when it comes to the size, shape and sustainability of Canada’s proverbial pot of gold,' argues analyst Stuart Rolfe...

on 12/10/18
Health

Andrew Left’s Citron Research sets $65 price target for Pyxus International stock, says it's 'a perfect hedge'

Pyxus shares soared after the short-seller released a report saying Pyxus would be the greatest beneficiary if tobacco giant Altria takes a stake in cannabis grower Aphria...

on 11/10/18
Health

Tobacco player Alliance One International turns over a new (and greener) leaf as Pyxus International

Bob Byrne explains what the company’s transformation as Pyxus International means for cannabis investors...

on 9/10/18
Health

Tilray and Cronos Group stock fall in holiday-tinged market dealings

Tilray has been rocked by volatile trading and Cronos has signed a string of partnerships in the cannabis space; New Age Beverage and DAVIDsTEA tumbled as well...

on 8/10/18
Health

Andrew Left’s Citron Research is shorting cannabis companies left and right, but not this one

The tobacco company’s Canadian subsidiary recently received a cannabis cultivation license from Health Canada...

on 8/10/18
Health

Short-seller Andrew Left’s Citron Research doubles down on Namaste Technologies, calls it a 'fraud'

Citron Research published a seven-page report that it claims proves the cannabis company is a fraud...

on 8/10/18
Health

Short-seller Andrew Left’s Citron Research sets sights on India Globalization Capital

The infrastructure-meets-pharmaceutical company recently announced a line of CBD-infused energy drinks...

on 2/10/18
Health

Why America's cannabis companies are flocking to Canada to woo public investors

The Canadian Securities Exchange is becoming a wildly popular destination for US cannabis companies rejected by the NYSE and Nasdaq...

on 28/9/18
Health

Andrew Left of Citron Research looking to create cannabis-fund, says Bloomberg

The fund would invest in Canadian-listed cannabis companies...

on 26/9/18
Health

Aleafia Health secures a spot on Horizons Marijuana Life Sciences ETF

The company recently teamed up with Cronos to study the effects of medical cannabis on insomnia...

on 21/9/18
Health

Cronos Group partners with Aleafia Health to work on medical cannabis study to treat insomnia

Physicians practicing within the Canabo Medical Clinic network, which is owned by Aleafia, will lead the study...

on 20/9/18
Health

Short-seller Andrew Left’s Citron Research says surge in cannabis company Tilray is 'beyond comprehension'

Left was previously bullish on Tilray but has since changed his tune...

on 19/9/18
Health

Beverage giant Coca-Cola interested in cannabis drinks, sending cannabis stocks higher

The Atlanta-based soft-drinks maker is in talks with Canadian marijuana producer Aurora Cannabis...

on 17/9/18
Health

StoneCastle Cannabis Growth Fund gives investors exposure to high-flying cannabis stocks

Fund manager Bruce Campbell tells cannabis investors to expect some ‘scary down days’ and consolidation before ‘the next phase up’...

on 14/9/18
Health

Cronos Group to launch second cannabis product in Canada called 'Spinach'

Canada is going to be the first G7 country to legalize cannabis in mid-October ...

on 13/9/18
Health

Cronos Group stock jumps after partnering with Boston biotech Ginkgo Bioworks in a US$122mln deal to develop cultured cannabinoids

The biotech will genetically engineer cannabinoids so that Cronos can bring cannabinoid-based products to market with reliability and scalability ...

on 4/9/18
Retail & consumer

Tilray is the latest pot stock to come under attack from short-seller Andrew Left's Citron Research

Declaring Tilray too expensive, Left and his team are now taking a short bet against the cannabis stock...

on 4/9/18
Finance

CryptoCann™ Report: Alibaba holds top spot for blockchain patents; Cronos inks deal for lab-grown cannabis

Cronos is partnering with Boston-based biotech Gingko Bioworks to develop lab-grown cannabis...

on 4/9/18
Finance

CannaRoyalty’s focus beyond Canada is more than just California Dreamin’

Unlike most Canadian operators, CannaRoyalty has opted to direct the bulk of its attention in California...

on 3/9/18
Health

Are marijuana stocks too high for an investor tempted to join the party, or do they have room to run?

Cronos stock recovers on Friday after saner voices intervened and defended the Canadian cannabis stock from a classic short-selling attack...

on 3/9/18
Retail & consumer

Cronos Group besieged by short-seller Andrew Left's Citron Research, shares fall and end sharply up Friday

The short selling firm calls Cronos the "most overhyped" of all the pot stocks and sets its price target at US$3.50...

on 31/8/18
Finance

CryptoCann™ Report: Bithumb exchange welcomes new users again after hack; Cronos enters the Latin American market

The Canadian cannabis company entered into a joint venture agreement to begin cultivation in Colombia...

on 29/8/18
Health

Cronos moves into Latin America with plans to cultivate cannabis in Colombia

The cannabis company entered a joint venture with an affiliate of Colombian agricultural provider Agroidea...

on 29/8/18